Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jorge Gomez

Showing results (131-140 of 144) with videos related to

Pageof 15
Sort By:
Scientific Reports|January 19, 2018
Developmental pathways inferred from modularity, morphological integration and fluctuating asymmetry patterns in the human faceMirsha Quinto-Sánchez, Francesc Muñoz-Muñoz, Jorge Gomez-Valdes, et al.
Iscience|March 18, 2021
A Drosophila platform identifies a novel, personalized therapy for a patient with adenoid cystic carcinomaErdem Bangi, Peter Smibert, Andrew V Uzilov, et al.
EMBO Molecular Medicine|March 7, 2023
RANK is a poor prognosis marker and a therapeutic target in ER-negative postmenopausal breast cancerMarina Ciscar, Eva M Trinidad, Gema Perez-Chacon, et al.
The Lancet. Oncology|March 1, 2023
Adjuvant paclitaxel and trastuzumab for node-negative, HER2-positive breast cancer: final 10-year analysis of the open-label, single-arm, phase 2 APT trialSara M Tolaney, Paolo Tarantino, Noah Graham, et al.
Plos Neglected Tropical Diseases|May 28, 2024
Novel paradigm enables accurate monthly gestational screening to prevent congenital toxoplasmosis and moreYing Zhou, Karen Leahy, Andrew Grose, et al.
Medrxiv : the Preprint Server for Health Sciences|June 5, 2026
Longitudinal multi-platform profiling reveals temporal dynamics of HER2, TROP2, PD-L1 and tumor-infiltrating lymphocytes in triple-negative breast cancerJorge Gomez Tejeda Zanudo, Busem Binboga Kurt, Allison Frangieh, et al.
Genome Medicine|June 27, 2026
ESR1 mutations and CDK4/6 inhibitor choice shape clonal selection and adaptive cell states during acquired resistanceCristina Guarducci, Daniel Abravanel, Douglas Russo, et al.
Contraception|May 14, 2003
A 13-month multicenter clinical experience of a low-dose monophasic oral contraceptive containing 20 microg ethinylestradiol and 75 microg gestodene in Latin American womenSusana Bassol, Gloria Alvarado, Ranferi Gaona Arreola, et al.
Journal of Ophthalmic Inflammation and Infection|September 24, 2025
Common data elements for observational studies in ocular toxoplasmosis: a Delphi consensusWilliam Rojas-Carabali, Carlos Cifuentes-González, Kerry Goetz, et al.
Nature|April 7, 2022
Ultrathin ferroic HfO<sub>2</sub>-ZrO<sub>2</sub> superlattice gate stack for advanced transistorsSuraj S Cheema, Nirmaan Shanker, Li-Chen Wang, et al.
Pageof 15

Showing results (131-140 of 144) with videos related to

Sort By:
Pageof 15
Scientific Reports|January 19, 2018
Developmental pathways inferred from modularity, morphological integration and fluctuating asymmetry patterns in the human faceMirsha Quinto-Sánchez, Francesc Muñoz-Muñoz, Jorge Gomez-Valdes, et al.
Iscience|March 18, 2021
A Drosophila platform identifies a novel, personalized therapy for a patient with adenoid cystic carcinomaErdem Bangi, Peter Smibert, Andrew V Uzilov, et al.
EMBO Molecular Medicine|March 7, 2023
RANK is a poor prognosis marker and a therapeutic target in ER-negative postmenopausal breast cancerMarina Ciscar, Eva M Trinidad, Gema Perez-Chacon, et al.
The Lancet. Oncology|March 1, 2023
Adjuvant paclitaxel and trastuzumab for node-negative, HER2-positive breast cancer: final 10-year analysis of the open-label, single-arm, phase 2 APT trialSara M Tolaney, Paolo Tarantino, Noah Graham, et al.
Plos Neglected Tropical Diseases|May 28, 2024
Novel paradigm enables accurate monthly gestational screening to prevent congenital toxoplasmosis and moreYing Zhou, Karen Leahy, Andrew Grose, et al.
Medrxiv : the Preprint Server for Health Sciences|June 5, 2026
Longitudinal multi-platform profiling reveals temporal dynamics of HER2, TROP2, PD-L1 and tumor-infiltrating lymphocytes in triple-negative breast cancerJorge Gomez Tejeda Zanudo, Busem Binboga Kurt, Allison Frangieh, et al.
Genome Medicine|June 27, 2026
ESR1 mutations and CDK4/6 inhibitor choice shape clonal selection and adaptive cell states during acquired resistanceCristina Guarducci, Daniel Abravanel, Douglas Russo, et al.
Contraception|May 14, 2003
A 13-month multicenter clinical experience of a low-dose monophasic oral contraceptive containing 20 microg ethinylestradiol and 75 microg gestodene in Latin American womenSusana Bassol, Gloria Alvarado, Ranferi Gaona Arreola, et al.
Journal of Ophthalmic Inflammation and Infection|September 24, 2025
Common data elements for observational studies in ocular toxoplasmosis: a Delphi consensusWilliam Rojas-Carabali, Carlos Cifuentes-González, Kerry Goetz, et al.
Nature|April 7, 2022
Ultrathin ferroic HfO<sub>2</sub>-ZrO<sub>2</sub> superlattice gate stack for advanced transistorsSuraj S Cheema, Nirmaan Shanker, Li-Chen Wang, et al.
Pageof 15